Showing results (171-180 of 205) with videos related to
Sort By:
Pageof 21
Journal of Medical Virology|November 1, 1991
Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell cultureL F Hung, A E Brumbaugh, G Bhatia, et al.Plos One|August 6, 2014
Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humansCleo Robinson, Helman Alfonso, Samantha Woo, et al.British Journal of Cancer|August 22, 2002
A multicentre phase II study of cisplatin and gemcitabine for malignant mesotheliomaA K Nowak, M J Byrne, R Williamson, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2Connie Jackaman, Christine S Bundell, Beverley F Kinnear, et al.Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Soluble mesothelin-related protein--a blood test for mesotheliomaBruce W S Robinson, Jenette Creaney, Richard Lake, et al.British Journal of Cancer|May 6, 2008
Overexpression and altered glycosylation of MUC1 in malignant mesotheliomaJ Creaney, A Segal, G Sterrett, et al.Annals of Internal Medicine|October 1, 1985
Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndromeH Burger, B Weiser, W S Robinson, et al.The American Journal of Medicine|July 1, 1986
Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all casesH Burger, B Weiser, W S Robinson, et al.Cancer Immunology, Immunotherapy : CII|December 5, 2008
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapyRobbert G van der Most, Andrew J Currie, Sathish Mahendran, et al.Chest|July 25, 2007
Combined CA125 and mesothelin levels for the diagnosis of malignant mesotheliomaJenette Creaney, Ivonne van Bruggen, Michelle Hof, et al.Pageof 21